Facebook
Twitter
LinkedIn
Forward
Comprehensive Review of Pain Medicine
Statement of Need
The University of Wisconsin School of Medicine and Public Health faculty in Pain Medicine, Family Medicine and Community Health, Anesthesiology, Neurology, Orthopedics and Rehabilitation, and the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) are pleased to offer the 16th Comprehensive Review of Pain Medicine at the Fluno Center in Madison, Wisconsin, August 13-17, 2018.
The current national opioid epidemic has brought into sharp focus the gaps in knowledge and training with respect to prevention, assessment and treatment of pain and opioid-related harm at all levels. Under-treatment as well as inappropriate pain management have contributed to suboptimal treatment outcomes, opioid use disorders, overdose, patient and provider dissatisfaction, and escalating national costs. This activity addresses knowledge and practice gaps in education and training in pain medicine.
This conference offers:
- Evidence-based lectures by nationally recognized expert multidisciplinary faculty
- Up-to-date, intensive review of Pain Medicine and related disorders for board certification/recertification
- Review of best clinical practices in pain management
- Topics of interest to Primary Care on Thursday, August 16, and Friday, August 17
- Education on judicious and balanced opioid use, risk assessment, mitigation, monitoring, strategies for opioid taper, and opioid-sparing treatment approaches
- Education about issues overlapping pain and opioid use disorders, the diagnosis and treatment of opioid addiction, and pain management approaches in individuals with opioid use disorder
Intended Audience
This activity has been planned by and for an interprofessional audience of clinicians, including pain medicine, addiction medicine, and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists interested in obtaining an overview of pain medicine.
Elements of Competence
This CE activity has been designed to the interprofessional (IP) areas of values/ethics for IP practice, roles/responsibilities, interprofessional communication and teams/teamwork.
Learning Objectives
At the conclusion of this educational activity, participants will be able to:
- Review the anatomy and neurophysiology of peripheral and central pain pathways.
- Describe mechanisms of pain in acute pain, chronic nociceptive and neuropathic pain.
- Develop effective and empathetic patient communication techniques, including communicating with patients and caregivers at “end of life” and those with challenging psychiatric comorbidities.
- Describe common psychiatric problems co-occurring with chronic pain, discuss role of psychological evaluation and testing, identify barriers to treatment, and evaluate evidence for common psychological and behavioral treatments.
- Recognize differences in assessment and management of patients with acute and postoperative pain, chronic non-cancer pain, cancer pain and end of life pain.
- Describe approaches to treating pain in special populations including children, the elderly, pregnant and lactating women, patients with cancer, and in palliative care settings.
- Describe the assessment and management of patients with headaches, complex regional pain syndrome, neuropathic pain, fibromyalgia, and pelvic pain.
- Recognize, interpret and clinically correlate radiological abnormalities in common musculoskeletal pain disorders of the spine and peripheral joints.
- Summarize the evidence for prolotherapy and other regenerative medicine treatments for musculoskeletal pain conditions.
- Discuss integrative medicine approaches to treating pain.
- Describe drug pharmacology and clinical applications of opioid and non-opioid analgesics and other pharmacotherapies for acute and chronic pain.
- Restate approaches aimed at improving the safety and efficacy of pain management with opioid analgesics: how to initiate, maintain, monitor compliance, taper and discontinue treatment with opioids.
- Describe current evidence for long-term opioid therapy in chronic non-cancer pain and adverse effects of long term opioid therapy.
- Summarize the diagnosis and treatment of opioid use disorder, and discuss ways to reduce harm in this patient population when treating pain.
- Explain the role of urine drug testing and discuss the interpretation of results.
- Discuss the problems of prescription opioid misuse/abuse in the chronic pain population.
- Articulate strategies for pain management in patients with opioid use disorder.
- Describe strategies to manage pain without opioids, including IV infusions, nerve blocks, neuromodulation, non-pharmacologic and CAM approaches
- Review the anatomy, indications, and contraindications for regional anesthetic blocks, cranial nerve and spinal injections, sympathetic blocks, and other advanced pain treatments.
- Discuss the management of patients with spinal cord stimulators and pain pumps.
- Discuss diagnostic workups in pain: indications and interpretations of imaging (plain x-rays, CT, and MRI) and electro-diagnostic testing.
- Outline a multimodal treatment plan for common pain conditions incorporating pharmacological, rehabilitation and behavioral/psychological, and interventional treatments.
- Recognize ethical and medico-legal issues related to pain medicine.
- Describe changes in policies and DEA regulations pertaining to prescribing schedule II and III medications, and record keeping.
Additional Information
| Attachment | Size |
|---|---|
 CompPainBrochure2018-F.pdf | 510.41 KB |
Monday, August 13, 2018
AM |
|
7:00 | Registration and Breakfast |
8:00 | Welcome |
8:15 | Acute Pain: Assessment and Management Overview – 2018 Oscar A. de Leon-Casasola, MD |
9:15 | Management of Postoperative Pain Oscar A. de Leon-Casasola, MD |
10:15 | Refreshment Break |
10:30 | Anatomy of Pain Pathways Tony L. Yaksh, PhD |
11:30 | Mechanisms of Post Tissue Pain States Tony L. Yaksh, PhD |
PM |
|
12:30 | Lunch |
1:30 | Intraspinal Analgesia for Acute and Chronic Pain Oscar A. de Leon-Casasola, MD |
2:30 | Mechanisms of Neuropathic Pain States Tony L. Yaksh, PhD |
3:30 | Refreshment Break |
3:45 | Receptors, Ion Channels and Channelopathies in Pain Thomas S. McDowell, MD, PhD |
4:45 | Assessing and Managing Pain in the Elderly Nathan J. Rudin, MD |
5:45 | Adjourn |
Tuesday, August 14, 2018
AM |
|
7:00 | Registration and Breakfast |
7:30 | Peripheral & Regional Nerve Blocks Thomas P. Broderick, MD |
8:30 | Sympathetic and Visceral Plexus Blocks Nalini Sehgal, MD |
9:30 | Refreshment Break |
9:45 | Cranial Nerve Blocks and Facial Pain Syndromes Alaa Abd-Elsayed, MD |
10:45 | Injection Procedures in Diagnosis & Treatment of Spinal Pain Nalini Sehgal, MD |
11:45 | Local Anesthetic Drugs: Pharmacology and Clinical Application Alaa Abd-Elsayed, MD |
PM |
|
12:30 | Lunch |
1:30 | Drug Pharmacology: Adjuvants June L. Dahl, PhD |
2:15
| Electrophysiologic Testing in Pain Assessments Nathan J. Rudin, MD, MA |
3:15 | Refreshment Break |
3:30 | Treating Pain in Pregnant and Breast Feeding Women Peter G. Pryde, MD |
4:30 | Diagnosis and Treatment of Peripheral and Central Neuropathic Pain Disorder Miroslav “Misha” Backonja, MD |
5:30 | Adjourn |
Wednesday, August 15, 2018
AM |
|
7:00 | Breakfast |
7:30 | Challenging Pain Patients: Recognizing Patients with Somatoform Disorders, Factitious and Malingering Conditions Rob Edwards, PhD, MSPH |
8:30 | Psychological Assessment in Chronic Pain: Why and How? Shilagh A. Mirgain, PhD |
9:30 | Acute and Chronic Pain in the Pediatric Population Timothy W. Casias, MD & Peggy S. Riley, MN, MPH, RN |
10:30 | Refreshment Break |
10:45 | Behavioral and Psychotherapeutic Interventions in Chronic Pain Shilagh A. Mirgain, PhD |
11:45 | Drug Pharmacology: NSAIDs, Acetaminophen, Antispasmodics Christi Ann Albert, PharmD BCPS |
PM |
|
12:30 | Lunch |
1:30 | Diagnosis, Treatment and Prevention of Primary Headache Disorders Susanne Seeger, MD |
2:30 | Classification and Pathophysiology of Headaches, Common Causes of Secondary Headache Disorders Susanne Seeger, MD |
3:30 | Refreshment Break |
3:45 | Cancer Pain: What Clinicians Should Know about Cancer Pain and Palliative Care Peggy Kim, MD, MS, MBA |
4:45 | Pelvic Pain: Assessment and Treatment Strategies Sarah E. McAchran, MD & Cara R. King, DO, MS |
5:45 | Adjourn |
Thursday, August 16, 2018
AM |
|
7:00 | Breakfast |
7:30 | Opioid Analgesics: Drug Classes, Mechanism of Action, Pharmacology and Adverse Effects June L. Dahl, PhD |
8:15 | Opioid Therapy in Chronic Pain: Initiation, Safety, Adherence Monitoring and Diagnosis of Addiction Randall T. Brown, MD, PhD |
9:00 | Opioids: Reducing, Stopping and Alternatives for Chronic Pain Brett R. Stacey, MD |
10:00 | Refreshment Break |
10:15 | Curbing Opioid Use: Role of Intravenous Lidocaine and Ketamine Infusions in Pain Paul R. Hutson, PharmD, BCOP |
11:00 | Myofascial Pain and Fibromyalgia Syndrome: An Update Nathan J. Rudin, MD, MA |
11:45
| Role of Spinal Cord Stimulation in Chronic Pain Treatment Brett R. Stacey, MD |
| PM | |
12:30 | Lunch |
1:30 | Complex Regional Pain Syndrome: Assessment and Treatment Brett R. Stacey, MD |
2:30 | DEA Regulations, Lawful Prescribing, Monitoring for Abuse and Diversion Aaron M. Gilson, MS, MSSW, PhD |
3:15 | Refreshment Break |
3:30 | Interpretation of Urine Drug Testing: Abnormal Results – What Now? John R. Ewing, MD |
4:15 | Opioid Use Disorder: Withdrawal Management and Addiction Treatment Michael M. Miller, MD, FASAM, FAPA |
5:00 | Pain Management in Patients with Opioid Use Disorder Aleksandra Zgierska, MD, PhD |
6:00 | Adjourn |
Friday, August 17, 2018
AM |
|
7:00 | Breakfast |
7:30 | Psychiatric Comorbidity in Chronic Pain Michael Clark, MD, MPH |
8:30 | Treatment of Depression and Anxiety in Chronic Pain: Primer of Psychiatric Medications for Providers Michael Clark, MD, MPH |
9:30 | Regenerative Medicine Treatments for Chronic Musculoskeletal Pain David Rabago, MD |
10:15 | Refreshment Break |
10:30 | Complementary and Alternative Medicine Treatments in Pain Management Russell L. Lemmon, DO |
11:30 | Ethical and Legal Considerations in Pain Medicine Arthur R. Derse, MD, JD |
PM |
|
12:30 | Lunch |
1:30 | Musculoskeletal and Spine Pain: Clinical Assessment with Radiological Correlation James W. Leonard, DO, PT & Donna G. Blankenbaker, MD |
3:30 | Adjourn |
Conference Housing
A block of rooms has been reserved at the Fluno Center. Please call the hotel directly to reserve your accommodation. The room rate is $159. The block of rooms will be held on a first-come, first served basis and any available rooms that have not been reserved by Friday, July 13, 2018, will be released.
Madison, Wisconsin has one major airport (MSN), the Dane County Regional Airport. The Fluno Center is approximately 20 minutes from the airport.
Conference Attire
Casual attire is appropriate for this conference. Since meeting room temperatures and personal comfort levels vary, it is recommended that you bring a sweater or jacket to the educational activity.
COURSE DIRECTOR
*Nalini Sehgal, MD
COURSE CO-DIRECTOR
*Aleksandra Zgierska, MD, PhD
PRESENTERS, MODERATORS & PLANNERS
VISITING FACULTY
Michael R. Clark, MD, MPH, MBA; Chair, Department of Psychiatry, Inova Fairfax Hospital, Falls Church, VA
Oscar A. de Leon-Casasola, MD; Professor of Anesthesiology and Medicine; Senior Vice-Chair, Department of Anesthesiology, University at Buffalo, School of Medicine; Chief, Division of Pain Medicine and Professor of Oncology, Roswell Park Cancer Institute, Buffalo, NY
Arthur R. Derse, MD, JD; Director, Center for Bioethics and Medical Humanities; Julia and David Uihlein Professor of Medical Humanities and Professor of Bioethics and Emergency Medicine, Institute for Health & Equity, Medical College of Wisconsin, Milwaukee, WI
Rob Edwards, PhD, MSPH; Associate Professor, Department of Anesthesiology, Brigham and Women’s Hospital, Chestnut Hill, MA
John R. Ewing, MD; Medical Co-Director of Addiction Medicine, UnityPoint Health – Meriter, NewStart Addiction and Substance Abuse Program, Madison, WI
Brett R. Stacey, MD; Medical Director, UW Center for Pain Relief; Professor, Anesthesiology & Pain Medicine; University of Washington, Seattle, WA
Tony L. Yaksh, PhD; Professor, Department of Anesthesiology and Professor of Pharmacology, University of California, San Diego, La Jolla, CA
UNIVERSITY OF WISCONSIN–MADISON FACULTY
*=Planning Committee member
Alaa Abd-Elsayed, MD;* Assistant Professor, Department of Anesthesiology; Medical Director, UW Health Pain Services; Medical Director, UW Pain Clinic
Christi Ann Albert, PharmD BCPS; Clinical Pharmacy, UW Health, University Hospital
Miroslav "Misha" Backonja, MD;* Emeritus Professor of Neurology, University of Wisconsin; Senior Medical Director, Worldwide Clinical Trials, Seattle WA
Terese M. Bailey;* Senior Outreach Specialist, Office of Continuing Professional Development in Medicine and Public Health, University of Wisconsin–Madison ICEP
Donna G. Blankenbaker, MD; Professor, Department of Radiology
Thomas P. Broderick, MD; Associate Professor, Department of Anesthesiology
Randall T. Brown, MD, PhD, DFASAM; Associate Professor, Department of Family Medicine & Community Health; Director, University Hospital Center for Addictive Disorders; Addictionologist, Madison VA Medical Center
Ruth Bruskiewitz; MS, RPh; Clinical Professor, Division of Pharmacy Professional Development, University of Wisconsin-Madison School of Pharmacy, University of Wisconsin–Madison ICEP
Timothy W. Casias, MD; Assistant Professor, Department of Anesthesiology; Medical Director of Pediatric Chronic Pain
June L. Dahl, PhD; Professor Emerita of Neuroscience
Aaron M. Gilson, MS, MSSW, PhD; Health Policy Research Scientist/Senior Scientist, Sonderegger Research Center, University of Wisconsin-Madison School of Pharmacy
Paul R. Hutson, PharmD, BCOP;* Professor, School of Pharmacy
Cheryl J. Kaltenberg;* Consultant
Peggy Kim, MD, MS, MBA; Assistant Professor, Department of Anesthesiology
Cara R. King, DO, MS; Assistant Professor, Department of Obstetrics & Gynecology
Russell L. Lemmon, DO; Assistant Professor, Department of Family Medicine & Community Health
James W. Leonard, DO, PT;* Associate Professor, Chair Division of Rehabilitation Medicine, Department of Orthopedics and Rehabilitation
Sarah E. McAchran, MD, FACS; Associate Professor, Departments of Urology and Obstetrics & Gynecology
Thomas S. McDowell, MD, PhD; Associate Professor, Department of Anesthesiology
Michael M. Miller, MD; Clinical Adjunct Professor, Department of Psychiatry
Shilagh A. Mirgain, PhD; Senior Psychologist, Clinical Adjunct Assistant Professor, Department of Orthopedics and Rehabilitation
Tracy Mrochek, MPA, RN; Continuing Education Program Coordinator, Continuing Education in Nursing, University of Wisconsin-Madison School of Nursing; University of Wisconsin–Madison ICEP
Peter G. Pryde, MD; Clinical Adjunct Associate Professor, Department of Anesthesiology; Director of Obstetric Anesthesiology, Unity Point Meriter Hospital; Anesthesiologist, Madison Anesthesiology Consultants, LLP
David Rabago, MD; Associate Professor, Department of Family Medicine & Community Health
Peggy S. Riley, MN, MPH, RN;* Pediatric Pain CNS, American Family Children’s Hospital; Adjunct Faculty, UW School of Nursing
Nathan J. Rudin, MD, MA;* Professor, Department of Orthopedics and Rehabilitation
Susanne Seeger, MD; Associate Professor and Vice Chair; Director, Headache Program, Department of Neurology
Nalini Sehgal, MD;* Professor, Department of Orthopedics and Rehabilitation; Fellowship Director, Pain Medicine; Vice Chair & Director Clinical Services, Rehabilitation Medicine
Aleksandra E. Zgierska, MD, PhD;* Assistant Professor, Family Medicine, Addiction Medicine, Department of Family Medicine & Community Health; Board of Directors member, Wisconsin Society of Addiction Medicine, American Society of Addiction Medicine
POLICY ON DISCLOSURE
It is the policy of the University of Wisconsin–Madison ICEP that the faculty, authors, planners, and other persons who may influence content of this CE activity disclose all relevant financial relationships with commercial interests in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s). For this educational activity, all conflicts of interest have been resolved and detailed disclosures are listed below:
Name of Individual | Individual’s Role In Activity | Name of Commercial Interest & Nature of Relationship | Discussion of |
Alaa Abd-Elsayed, MD | Presenter | Axsome, Halyard, Sollis, Spineloop (Consultant) | No |
Christi Albert, PharmD | Presenter | No relevant financial relationships to disclose | No |
Miroslav “Misha” Backonja, MD | Planner & Presenter | PRA International (Employee) | No |
Terese Bailey | Planner | No relevant financial relationships to disclose | No |
Donna G. Blankenbaker, MD | Presenter | No relevant financial relationships to disclose | No |
Thomas P. Broderick, MD | Presenter | No relevant financial relationships to disclose | Yes |
Randall T. Brown, MD, PhD | Presenter | No relevant financial relationships to disclose | No |
Ruth Bruskiewitz, MS, RPh | Planner | No relevant financial relationships to disclose | No |
Timothy Casias, MD | Presenter | No relevant financial relationships to disclose | Yes |
Michael R. Clark, MD, MPH, MBA | Presenter | No relevant financial relationships to disclose | Yes |
June L. Dahl, PhD | Presenter | No relevant financial relationships to disclose | No |
Oscar A. de Leon-Casasola, MD | Presenter | AstraZeneca (Consultant) | Yes |
Arthur R. Derse, MD, JD | Presenter | No relevant financial relationships to disclose | No |
Rob Edwards, PhD, MSPH | Presenter | No relevant financial relationships to disclose | No |
John R. Ewing, MD | Presenter | No relevant financial relationships to disclose | No |
Aaron M. Gilson, MS, MSSW, PhD | Presenter | No relevant financial relationships to disclose | No |
Paul R. Hutson, PharmD, BCOP | Planner & Presenter | Projections Research, Inc. (Consultant) | No |
Cheryl J. Kaltenberg | Planner | No relevant financial relationships to disclose | No |
Peggy Kim, MD, MS, MBA | Presenter | Semnur Pharmaceuticals (PI) | No |
Cara King, DO, MS | Presenter | No relevant financial relationships to disclose | No |
Russell Lemmon, DO | Presenter | No relevant financial relationships to disclose | No |
James W. Leonard, DO, PT | Planner & Presenter | No relevant financial relationships to disclose | No |
Sarah E. McAchran, MD | Presenter | Pfizer (Stockholder Or Other Ownership Interest Holder) | No |
Thomas S. McDowell, MD, PhD | Presenter | No relevant financial relationships to disclose | Yes |
Michael M. Miller, MD | Presenter | Ammon Labs, Biodelivery Sciences, Braeburn Pharmaceuticals, Curry Rockfeller Group (Consultant); Biodelivery Sciences, US Worldmeds (Member of Advisory Committee Or Review Panel); Braeburn Pharmaceuticals (Teacher/Speaker) | Yes |
Shilagh A. Mirgain, PhD | Presenter | No relevant financial relationships to disclose | No |
Tracy Mrochek, MPA, RN | Planner | No relevant financial relationships to disclose | No |
Peter G. Pryde, MD | Presenter | No relevant financial relationships to disclose | No |
David P. Rabago, MD | Presenter | No relevant financial relationships to disclose | Yes |
Peggy S. Riley, MN, MPH, RN | Planner & Presenter | No relevant financial relationships to disclose | No |
Nathan J. Rudin, MD, MA | Planner & Presenter | No relevant financial relationships to disclose | No |
Susanne K. Seeger, MD | Presenter | No relevant financial relationships to disclose | No |
Nalini Sehgal, MD | Planner & Presenter | No relevant financial relationships to disclose | No |
Brett R. Stacey, MD | Presenter | Kineta, Teva Pharmaceuticals (Consultant); Axsome, Pfizer, Vertex Pharmaceuticals Inc. (PI) | Yes |
Tony L. Yaksh, PhD | Presenter | Kalyra Pharmaceuticals, Teva Pharmaceuticals (Consultant); Advanced Targeting, Alyrxx Inc., Ark Animal Health, Asana, Concentric, Epigen, Flowonix, Ipsen, Medtronic, Inc., Sanford Burnham Consortium, Sorrento Therapeutics Inc., Switch Biotherapeutics (PI) | No |
Aleksandra E. Zgierska, MD, PhD | Planner & Presenter | No relevant financial relationships to disclose | No |
Accreditation Statement
 | In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. |
Credit Designation Statements
Accreditation Council for Pharmacy Education (ACPE)
A maximum of 41 hours of knowledge-based CE credit can be earned by successfully completing this live activity. Pharmacists should claim only the credit commensurate with the extent of their participation in the activity. CE credit information, based on verification of live attendance and completion of the program assessment and evaluation, will be provided to NABP within 60 days after the activity completion.
Universal Activity Number (UAN) JA0000358-0000-18-079-L01-P 39.25 hours/3.925 CEUs
Universal Activity Number (UAN) JA0000358-0000-18-080-L03-P 1.75 hours/.175 CEUs
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 41 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC) & Iowa Board of Nursing
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 41 ANCC and Iowa contact hours (17.75 of which are eligible for pharmacotherapeutic contact hours).
The University of Wisconsin–Madison School of Nursing is Iowa Board of Nursing provider 350. A copy of the evaluation(s) may be sent to the Iowa Board of Nursing, 400 SW 8th St., Suite B, Des Moines, IA 50309.
Continuing Education Units
The University of Wisconsin–Madison, as a member of the University Continuing Education Association (UCEA), authorizes this program for .41 continuing education units (CEUs) or 41 hours.
American Academy of Family Medicine
This Live activity, Comprehensive Review of Pain Medicine, with a beginning date of 08/13/2018, has been reviewed and is acceptable for up to 41.00 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Board of Addiction Medicine
This course has been approved by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Transitional Maintenance of Certification (tMOC) Program can apply for a maximum of 5 AMA PRA Category 1 CreditsTM for completing the Comprehensive Review of Pain Medicine course.
POLICY ON FACULTY AND SPONSOR DISCLOSURE
It is the policy of the University of Wisconsin–Madison ICEP, that the faculty, authors, planners, and other persons who may influence content of this CE activity disclose all relevant financial relationships with commercial interests in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s).
Detailed disclosures will be available prior to the start of the activity.
Available Credit
- 5.00 TraCC: ABAM SAMs Points (Part II)
- 41.00 ACPE Contact Hours - Pharmacist
- 41.00 AMA PRA Category 1 Credit™
- 41.00 ANCC Contact Hours
- 41.00 Iowa Board of Nursing Contact Hours
- 41.00 University of Wisconsin–Madison Continuing Education Hours
REGISTRATION DEADLINE: August 10, 2018
The conference fee includes the cost of tuition, materials, breakfasts, lunches, refreshment breaks, and a nonrefundable processing fee of $50.
Course Materials
Conference materials will be available to registered participants on Wednesday, August 8.
Participants may purchase a paper copy of the syllabus for an additional fee of $94.95 (price includes all applicable taxes).
Requests must be received by Wednesday, July 25, 2018.
If there are any concerns regarding the electronic syllabus, please contact Terese Bailey or Cheryl Kaltenberg prior to the Symposium.
CANCELLATION AND REFUND POLICY
Requests for cancellation must be submitted in writing to help@icep.wisc.edu. Cancellation requests received by August 6, 2018 to allow a full refund except for the $50 nonrefundable processing fee. No refunds will be made for cancellations received after August 6, 2018.
QUESTIONS ABOUT REGISTRATION
Email help@icep.wisc.edu or call 608-262-7226
PROGRAM CHANGES
Emergency situations occasionally occur and may necessitate topic or speaker changes. The University of Wisconsin School of Medicine and Public Health and the University of Wisconsin–Madison ICEP reserve the right to alter or substitute a topic or speaker without prior notification.
FOR FURTHER INFORMATION
For conference information or details, please contact Terese Bailey at 608.265.2046 or terese.bailey@wisc.edu